⚡ 本页包含 AI 生成的分析内容,仅供参考
本文提出了一种受RFID启发的一步封装多模式生物分析仪,采用真空微流体技术,用于即时诊断。该设备旨在解决低浓度分子生物标志物检测中需要集中实验室的问题,提供比传统纸基侧流免疫分析更准确的定量结果。
low-concentration molecular biomarkers requires sending samples to centralized labs, leading to high costs and delays (Fig. 20.3.1). Recent developments in molecular diagnostics thus aim to enable point-of-care (POC) detection directly at or near the patient’s location [1–2]. The most successful POC technology to date is the paper-based lateral-flow assay (LFA) [3–4]. Examples include pregnancy tests that sense progesterone and SARS-CoV-2 rapid antigen tests. However, paper-based assays generally provide binary results or limited quantitative accuracy. On the other hand, the miniaturization of instrumentation, such as Abbott i-Stat Alinity, has enabled accurate diagnostics in hospital settings [5–6]. However, these devices remain costly and
Yan-Ting Hsiao1, Ya-Chen Tsai1, Wei Foo1, Hung-Yu Hou1, Yun-Chun Su2,
Yueting Lily Li1, Jun-Chau Chien1 University of California, Berkeley, CA National Taiwan University, Taipei City, Taiwan 1 2 Current clinical practice for detecting